Delivery Order SPE2DB20D3505-SPE2DB23FU7D4
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM. The contract has a ceiling value of $1,124.96 and a completion date of May 2, 2023. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,238.13 firm fixed-price delivery order is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with a completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a $2,394.95 Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical pharmaceutical product, to support military healthcare programs. This award is part of Amerisourcebergen's broader $999,999,999 IDC with the DLA, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.96 delivery order is for the supply of Albuterol HFA 90 MCG inhalers, with an ultimate completion date of November 15, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC...
- This contract award is for the delivery of Albuterol HFA 90 MCG Inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as a Firm Fixed Price Delivery Order under their Indefinite Delivery Contract (IDC) with the DLA. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $1,178.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,362,344 units of the pharmaceutical product Albuterol HFA 90 MCG Inhaler 8.5 GM. The contract is a firm fixed-price delivery order with a completion date of March 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $1,008.48, is for the supply of 90 mcg Albuterol HFA inhalers. The contract has an ultimate completion date of May 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Albuterol HFA 90 MCG Inhalers (8.5 GM) to the Defense Logistics Agency (DLA). The $1,031.01 firm-fixed-price delivery order was issued on December 8, 2022, with a completion date of December 9, 2022. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide...
- This federal contract award, valued at $1,853.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical pharmaceutical product used for respiratory care. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $6,493.59 for the procurement of Albuterol HFA 90 MCG inhalers. The contract has a completion date of September 24, 2021 and was awarded on a Firm Fixed Price basis with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU7D4Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of Albuterol HFA 90 MCG inhalers to the Defense Logistics Agency (DLA). The $7,140.17 firm fixed-price delivery order has a completion date of September 12, 2023 and is not associated with any set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items, to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/11/23 |